in vitro-treated bone marrow transplantation [clinicaltrials_resource:f747f7fe66b5d2470544c36405d3a72c]
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002461]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer [clinicaltrials:NCT00002515]Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission [clinicaltrials:NCT00002534]Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [clinicaltrials:NCT00002552]Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002592]Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma [clinicaltrials:NCT00002634]Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma [clinicaltrials:NCT00003187]Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00003877]Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003960]Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00004255]Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00005641]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00005854]Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [clinicaltrials:NCT00005988]Bone Marrow Transplantation in Treating Patients With Leukemia [clinicaltrials:NCT00006451]Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia [clinicaltrials:NCT00245115]Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [clinicaltrials:NCT00265837]
intervention [clinicaltrials_vocabulary:intervention]
in vitro-treated bone marrow transplantation [clinicaltrials_resource:f747f7fe66b5d2470544c36405d3a72c]
Bio2RDF identifier
f747f7fe66b5d2470544c36405d3a72c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f747f7fe66b5d2470544c36405d3a72c
intervention name [clinicaltrials_vocabulary:intervention-name]
in vitro-treated bone marrow transplantation
identifier
clinicaltrials_resource:f747f7fe66b5d2470544c36405d3a72c
title
in vitro-treated bone marrow transplantation
@en
type
label
in vitro-treated bone marrow t ...... 7f7fe66b5d2470544c36405d3a72c]
@en